PharmiWeb

NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease ...
PharmiWeb

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units ...

CHICAGO, IL / ACCESS Newswire / April 13, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that ...
PharmiWeb

From Fitness Bands to Smart Health: Wearable Technology Industry on the Rise!

Wearable technology has quietly moved beyond being just another category of consumer gadgets—it’s becoming part of how people make everyday decisions. What started with simple step counters has ...
PharmiWeb

Artificial Intelligence in Drug Discovery Market: Trends, Growth, and Forecast

Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...
PharmiWeb

AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and ...
PharmiWeb

Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities

Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with ...
PharmiWeb

Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression ...

Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...
PharmiWeb

Dr. David W. Allison Brings His Expertise in Breast and Body Surgery to Becker Aesthetics & Plastic Surgery

Board-certified plastic surgeon expands his practice to serve patients in Princeton, NJ and Philadelphia, PA. PRINCETON, NJ AND PHILADELPHIA, PA / ACCESS Newswire / April 13, 2026 / Dr. David W.
PharmiWeb

Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors

Appointments add clinical development, translational oncology, company-building, and strategic investment expertise as Orum advances its next wave of degrader-antibody conjugate programsBOSTON & ...
PharmiWeb

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria

Phase 1 Study Will Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EDP-978 in Healthy VolunteersTopline Data Expected in Q4 2026WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta ...
PharmiWeb

Lineage Announces Formation of Scientific Advisory Board

LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
PharmiWeb

Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs

Global Market for Short Bowel Syndrome, Including Intestinal Failure (IF), Estimated to Reach $8.0 Billion by 20331AI data mining of real world clinical and symptom manifestation is beneficial in the ...